Venous thromboembolism in COVID-19 and inherited thrombophilia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | https://doi.org/10.1016/j.htct.2022.08.001 http://hdl.handle.net/1843/61760 https://orcid.org/0000-0002-5257-9507 |
Resumo: | In December 2019, the first cases of a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2; COVID-19) were detected in Wuhan, China.1 SARS-coV-2 is a highly infectious virus which leads to heterogeneous clinical manifestations.1 Some individuals remain asymptomatic, while others, especially individuals with comorbidities, are more prone to develop severe manifestations of the disease.2 SARSCoV-2 leads to extensive inflammation, endothelial damage, platelet activation and hypercoagulability, characterizing a prothrombotic state.2 Advanced age, diabetes, obesity and hypertension are associated with a higher risk of thromboembolic complications in COVID-19.2 However, little is known about potential interaction between COVID-19 and hereditary thrombophilia and its effect on thrombotic risk.3 Antithrombin (AT) is a physiological inhibitor of coagulation, mainly of thrombin, but also of factors Xa, IXa and others.4 AT deficiency is an autosomal dominant hereditary disorder, with variable penetrance and equal distribution between sexes.4 Patients with AT deficiency are at significantly increased risk of thromboembolism, especially venous (VTE).4 Of all hereditary thrombophilias, AT deficiency is the one with the highest risk of VTE.4 The aim of this article is to report a case of a young man with AT deficiency and prothrombin mutation G20210A who, 7 days after the onset of COVID-19, developed an episode of deep venous thrombosis (DVT) in the right leg. |
id |
UFMG_cf142966f17d83cfaf767b417eb6d085 |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/61760 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
2023-12-05T20:48:56Z2023-12-05T20:48:56Z202213https://doi.org/10.1016/j.htct.2022.08.0012531-1379http://hdl.handle.net/1843/61760https://orcid.org/0000-0002-5257-9507In December 2019, the first cases of a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2; COVID-19) were detected in Wuhan, China.1 SARS-coV-2 is a highly infectious virus which leads to heterogeneous clinical manifestations.1 Some individuals remain asymptomatic, while others, especially individuals with comorbidities, are more prone to develop severe manifestations of the disease.2 SARSCoV-2 leads to extensive inflammation, endothelial damage, platelet activation and hypercoagulability, characterizing a prothrombotic state.2 Advanced age, diabetes, obesity and hypertension are associated with a higher risk of thromboembolic complications in COVID-19.2 However, little is known about potential interaction between COVID-19 and hereditary thrombophilia and its effect on thrombotic risk.3 Antithrombin (AT) is a physiological inhibitor of coagulation, mainly of thrombin, but also of factors Xa, IXa and others.4 AT deficiency is an autosomal dominant hereditary disorder, with variable penetrance and equal distribution between sexes.4 Patients with AT deficiency are at significantly increased risk of thromboembolism, especially venous (VTE).4 Of all hereditary thrombophilias, AT deficiency is the one with the highest risk of VTE.4 The aim of this article is to report a case of a young man with AT deficiency and prothrombin mutation G20210A who, 7 days after the onset of COVID-19, developed an episode of deep venous thrombosis (DVT) in the right leg.engUniversidade Federal de Minas GeraisUFMGBrasilHCL - HOSPITAL DAS CLINICASMED - DEPARTAMENTO DE CLÍNICA MÉDICAHematology, Transfusion and Cell TherapyTromboembolia VenosaCOVID-19Venous thromboembolismInherited thrombophiliaCOVID-19Venous thromboembolism in COVID-19 and inherited thrombophiliainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://www.sciencedirect.com/science/article/pii/S2531137922013074?via%3DihubEster Martins Camillozzi MedinaDaniel Dias RibeiroMaria Sueli Silva Namen-LopesSuely Meireles Rezendeapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/61760/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALVenous thromboembolism in COVID-19 and inherited thrombophilia.pdfVenous thromboembolism in COVID-19 and inherited thrombophilia.pdfapplication/pdf144866https://repositorio.ufmg.br/bitstream/1843/61760/2/Venous%20thromboembolism%20in%20COVID-19%20and%20inherited%20thrombophilia.pdf123a688f6d0c07bce0a14eb29d5eac44MD521843/617602023-12-05 17:48:56.288oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-12-05T20:48:56Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.pt_BR.fl_str_mv |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
title |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
spellingShingle |
Venous thromboembolism in COVID-19 and inherited thrombophilia Ester Martins Camillozzi Medina Venous thromboembolism Inherited thrombophilia COVID-19 Tromboembolia Venosa COVID-19 |
title_short |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
title_full |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
title_fullStr |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
title_full_unstemmed |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
title_sort |
Venous thromboembolism in COVID-19 and inherited thrombophilia |
author |
Ester Martins Camillozzi Medina |
author_facet |
Ester Martins Camillozzi Medina Daniel Dias Ribeiro Maria Sueli Silva Namen-Lopes Suely Meireles Rezende |
author_role |
author |
author2 |
Daniel Dias Ribeiro Maria Sueli Silva Namen-Lopes Suely Meireles Rezende |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Ester Martins Camillozzi Medina Daniel Dias Ribeiro Maria Sueli Silva Namen-Lopes Suely Meireles Rezende |
dc.subject.por.fl_str_mv |
Venous thromboembolism Inherited thrombophilia COVID-19 |
topic |
Venous thromboembolism Inherited thrombophilia COVID-19 Tromboembolia Venosa COVID-19 |
dc.subject.other.pt_BR.fl_str_mv |
Tromboembolia Venosa COVID-19 |
description |
In December 2019, the first cases of a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2; COVID-19) were detected in Wuhan, China.1 SARS-coV-2 is a highly infectious virus which leads to heterogeneous clinical manifestations.1 Some individuals remain asymptomatic, while others, especially individuals with comorbidities, are more prone to develop severe manifestations of the disease.2 SARSCoV-2 leads to extensive inflammation, endothelial damage, platelet activation and hypercoagulability, characterizing a prothrombotic state.2 Advanced age, diabetes, obesity and hypertension are associated with a higher risk of thromboembolic complications in COVID-19.2 However, little is known about potential interaction between COVID-19 and hereditary thrombophilia and its effect on thrombotic risk.3 Antithrombin (AT) is a physiological inhibitor of coagulation, mainly of thrombin, but also of factors Xa, IXa and others.4 AT deficiency is an autosomal dominant hereditary disorder, with variable penetrance and equal distribution between sexes.4 Patients with AT deficiency are at significantly increased risk of thromboembolism, especially venous (VTE).4 Of all hereditary thrombophilias, AT deficiency is the one with the highest risk of VTE.4 The aim of this article is to report a case of a young man with AT deficiency and prothrombin mutation G20210A who, 7 days after the onset of COVID-19, developed an episode of deep venous thrombosis (DVT) in the right leg. |
publishDate |
2022 |
dc.date.issued.fl_str_mv |
2022 |
dc.date.accessioned.fl_str_mv |
2023-12-05T20:48:56Z |
dc.date.available.fl_str_mv |
2023-12-05T20:48:56Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1843/61760 |
dc.identifier.doi.pt_BR.fl_str_mv |
https://doi.org/10.1016/j.htct.2022.08.001 |
dc.identifier.issn.pt_BR.fl_str_mv |
2531-1379 |
dc.identifier.orcid.pt_BR.fl_str_mv |
https://orcid.org/0000-0002-5257-9507 |
url |
https://doi.org/10.1016/j.htct.2022.08.001 http://hdl.handle.net/1843/61760 https://orcid.org/0000-0002-5257-9507 |
identifier_str_mv |
2531-1379 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Hematology, Transfusion and Cell Therapy |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.publisher.initials.fl_str_mv |
UFMG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
HCL - HOSPITAL DAS CLINICAS MED - DEPARTAMENTO DE CLÍNICA MÉDICA |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
bitstream.url.fl_str_mv |
https://repositorio.ufmg.br/bitstream/1843/61760/1/License.txt https://repositorio.ufmg.br/bitstream/1843/61760/2/Venous%20thromboembolism%20in%20COVID-19%20and%20inherited%20thrombophilia.pdf |
bitstream.checksum.fl_str_mv |
fa505098d172de0bc8864fc1287ffe22 123a688f6d0c07bce0a14eb29d5eac44 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
|
_version_ |
1803589575982972928 |